Status:
COMPLETED
Drug Interaction Study With Proton Pump Inhibitor
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
HIV Infections
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of this clinical research study is to assess the effect of omeprazole at 20 mg on the pharmacokinetics of atazanavir administered as atazanavir with ritonavir relative to atazanavir or ata...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy male and female subjects between the ages of 18 to 50 years old with BMI 18 to 32 kg/m2
Exclusion
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
End Date :
August 1 2006
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00357240
Start Date
June 1 2006
End Date
August 1 2006
Last Update
April 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Hamilton, New Jersey, United States